Vistacare Medical and Quantum Genomics enter into exclusive negotiations with the ambition of creating a reference player in the management of complex wounds
VistaCare Medical, a French medtech company developing innovative technology for the treatment of complex wounds, and Quantum Genomics, a biopharmaceutical company listed on the Euronext Growth market in Paris, have entered into exclusive negotiations to create a leading player in the field of complex wound management. For more information please see our press release. Press...